{"id":21611,"date":"2020-04-06T12:10:03","date_gmt":"2020-04-06T17:10:03","guid":{"rendered":"https:\/\/osteopathic.org\/?page_id=21611"},"modified":"2020-04-09T19:51:03","modified_gmt":"2020-04-10T00:51:03","slug":"affiliate-advocacy-opportunities-resources","status":"publish","type":"page","link":"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/","title":{"rendered":"COVID-19 Addiction Medicine Resources"},"content":{"rendered":"<p><strong>U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) <a href=\"https:\/\/www.samhsa.gov\/coronavirus\" target=\"_blank\" rel=\"noopener noreferrer\">COVID-19 Resources<\/a><\/strong><\/p>\n<ul>\n<li>SAMHSA has <a href=\"https:\/\/www.samhsa.gov\/sites\/default\/files\/otp-guidance-20200316.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">announced<\/a>\u00a0that it will allow State Opioid Treatment Authorities (SOTAs) to request blanket exceptions to allow patients with substance use disorder to obtain up to 28 days of Take Home medication if they are stable, and up to 14 days for patients who are less stable but who the OTP believes can safely handle that level of Take Home medication.\u00a0State affiliates are encouraged to reach out to their\u00a0<a href=\"https:\/\/dpt2.samhsa.gov\/regulations\/smalist.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">SOTAs<\/a> to urge them to make this request.<\/li>\n<\/ul>\n<p><strong>Drug Enforcement Agency (DEA) <a href=\"https:\/\/www.deadiversion.usdoj.gov\/coronavirus.html\" target=\"_blank\" rel=\"noopener noreferrer\">COVID-19 Resources<\/a><\/strong><\/p>\n<ul>\n<li>On March 31, the DEA issued new <a href=\"https:\/\/www.samhsa.gov\/sites\/default\/files\/dea-samhsa-buprenorphine-telemedicine.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">guidance<\/a>\u00a0providing flexibility for physicians managing patients with opioid use disorder.\u00a0Previously, physicians were required to conduct an in-person evaluation before prescribing buprenorphine to new patients for the treatment of opioid use disorder; however, in light of the current national crisis, the DEA has announced that the initial visit may be conducted via telephone (voice) calls, if the physician believes that an adequate evaluation may be accomplished via telephone. The new policy is effective from March 31 for the duration of the COVID-19 emergency.<\/li>\n<\/ul>\n<p><strong>National Institute on Drug Abuse (NIDA) <a href=\"https:\/\/www.drugabuse.gov\/about-nida\/noras-blog\/2020\/03\/covid-19-potential-implications-individuals-substance-use-disorders\" target=\"_blank\" rel=\"noopener noreferrer\">COVID-19 Resources<\/a><\/strong><\/p>\n<p><strong>American Osteopathic Academy of Addiction Medicine (AOAAM) <a href=\"https:\/\/www.aoaam.org\/COVID-19\" target=\"_blank\" rel=\"noopener noreferrer\">COVID-19 Resources<\/a><\/strong><\/p>\n<p><strong>Opioid Task Force:\u00a0<a href=\"https:\/\/www.end-opioid-epidemic.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">End the Opioid Epidemic<\/a><\/strong><\/p>\n<ul>\n<li>Opioid Task Force issues new <a href=\"https:\/\/www.end-opioid-epidemic.org\/wp-content\/uploads\/2019\/05\/2019-AMA-Opioid-Task-Force-Recommendations-FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">recommendations<\/a> to urge policymakers to protect patients\u2019 access to evidence-based treatment, remove barriers to comprehensive pain care<\/li>\n<li><a href=\"https:\/\/www.end-opioid-epidemic.org\/wp-content\/uploads\/2017\/08\/AMA-Opioid-Task-Force-naloxone-one-pager-updated-August-2017-FINAL-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Help save lives: Co-prescribe naloxone to patients at risk of overdose<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) COVID-19 Resources SAMHSA has announced\u00a0that it will allow State Opioid Treatment Authorities (SOTAs) to request blanket exceptions to allow patients with substance use disorder to obtain up to 28 days of Take Home medication if they are stable, and up to 14 days for patients who &hellip; <a href=\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/\" class=\"readmore\">Read More<\/a><\/p>\n","protected":false},"author":30513,"featured_media":0,"parent":20871,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>COVID-19 Addiction Medicine Resources - American Osteopathic Association<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 Addiction Medicine Resources\" \/>\n<meta property=\"og:description\" content=\"U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) COVID-19 Resources SAMHSA has announced\u00a0that it will allow State Opioid Treatment Authorities (SOTAs) to request blanket exceptions to allow patients with substance use disorder to obtain up to 28 days of Take Home medication if they are stable, and up to 14 days for patients who &hellip; Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/\" \/>\n<meta property=\"og:site_name\" content=\"American Osteopathic Association\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-10T00:51:03+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/\",\"url\":\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/\",\"name\":\"COVID-19 Addiction Medicine Resources - American Osteopathic Association\",\"isPartOf\":{\"@id\":\"https:\/\/osteopathic.org\/#website\"},\"datePublished\":\"2020-04-06T17:10:03+00:00\",\"dateModified\":\"2020-04-10T00:51:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/osteopathic.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practicing Medicine\",\"item\":\"https:\/\/osteopathic.org\/practicing-medicine\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Providing Care\",\"item\":\"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"ARCHIVE: COVID-19\",\"item\":\"https:\/\/osteopathic.org\/?page_id=20871\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"COVID-19 Addiction Medicine Resources\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/osteopathic.org\/#website\",\"url\":\"https:\/\/osteopathic.org\/\",\"name\":\"American Osteopathic Association\",\"description\":\"Advancing the distinctive philosophy and practice of osteopathic medicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/osteopathic.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"COVID-19 Addiction Medicine Resources - American Osteopathic Association","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/","og_locale":"en_US","og_type":"article","og_title":"COVID-19 Addiction Medicine Resources","og_description":"U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) COVID-19 Resources SAMHSA has announced\u00a0that it will allow State Opioid Treatment Authorities (SOTAs) to request blanket exceptions to allow patients with substance use disorder to obtain up to 28 days of Take Home medication if they are stable, and up to 14 days for patients who &hellip; Read More","og_url":"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/","og_site_name":"American Osteopathic Association","article_modified_time":"2020-04-10T00:51:03+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/","url":"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/","name":"COVID-19 Addiction Medicine Resources - American Osteopathic Association","isPartOf":{"@id":"https:\/\/osteopathic.org\/#website"},"datePublished":"2020-04-06T17:10:03+00:00","dateModified":"2020-04-10T00:51:03+00:00","breadcrumb":{"@id":"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/covid-19-resources\/affiliate-advocacy-opportunities-resources\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/osteopathic.org\/"},{"@type":"ListItem","position":2,"name":"Practicing Medicine","item":"https:\/\/osteopathic.org\/practicing-medicine\/"},{"@type":"ListItem","position":3,"name":"Providing Care","item":"https:\/\/osteopathic.org\/practicing-medicine\/providing-care\/"},{"@type":"ListItem","position":4,"name":"ARCHIVE: COVID-19","item":"https:\/\/osteopathic.org\/?page_id=20871"},{"@type":"ListItem","position":5,"name":"COVID-19 Addiction Medicine Resources"}]},{"@type":"WebSite","@id":"https:\/\/osteopathic.org\/#website","url":"https:\/\/osteopathic.org\/","name":"American Osteopathic Association","description":"Advancing the distinctive philosophy and practice of osteopathic medicine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/osteopathic.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/osteopathic.org\/wp-json\/wp\/v2\/pages\/21611"}],"collection":[{"href":"https:\/\/osteopathic.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/osteopathic.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/osteopathic.org\/wp-json\/wp\/v2\/users\/30513"}],"replies":[{"embeddable":true,"href":"https:\/\/osteopathic.org\/wp-json\/wp\/v2\/comments?post=21611"}],"version-history":[{"count":0,"href":"https:\/\/osteopathic.org\/wp-json\/wp\/v2\/pages\/21611\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/osteopathic.org\/wp-json\/wp\/v2\/pages\/20871"}],"wp:attachment":[{"href":"https:\/\/osteopathic.org\/wp-json\/wp\/v2\/media?parent=21611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}